BENEFITS OF EARLY SCREENING AND PROPER TREATMENT IN PATIENT WITH SIGNIFICANT RISK FACTORS FOR GESTATIONAL DIABETES MELLITUS (CASE REPORT).
Gestational diabetes mellitus (GDM) occurs in 2-9% of all pregnancies. Evidence suggests that the use of insulin in treating hyperglycemia in GDM patients reduces the risk of perinatal morbidity. Pregnancy is an exciting time in a woman's life. However, once patient is diagnosed with GDM, she will be managed more intensively. GDM is managed using diet and exercise but one in six women with GDM requires insulin. A 35-year-old woman at the 14th gestational week of her tenth pregnancy was seen for routine prenatal care. She had the history of nine consecutive spontaneous abortions. Patient was hospitalized and based on the revealed glucose values insulin therapy was initiated with long-acting insulin analogue - Levemir and rapid-acting insulin analogue - NovoRapid. Patient's diabetes was compensated on insulin therapy. Follow-ups were planned at intervals of 1-2 weeks depending on the glucose levels. This is the case report of a GDM in a high-risk patient. She's at the 21st gestational weeks and has passed "delicate weeks". At her 21st week of gestation patient's glucose levels are compensated on insulin therapy and she is feeling well. In this unusual case report, no insulin therapy had been started during previous pregnancies, so we managed to achieve a good glycemic control with insulin treatment. This could be one of the factors that could help a normal pregnancy and delivery. The discussion should be focusing on early screening and proper treatment for GDM.